Posted by Michael Wonder on 21 Apr 2021
J&J resumes roll-out of COVID-19 vaccine in EU
21 April 2021 - Johnson & Johnson is planning to resume the roll-out of its COVID-19 vaccine in the EU following updated guidance from the EMA safety committee.
The EMA’s Pharmacovigilance Risk Assessment Committee has reviewed a small number of cases of very rare blood clots in combination with low platelet counts in individuals who have received the Johnson & Johnson vaccine.
